Nexentis Technologies NXTS
NASDAQ NXTS
$1.69 +0.02 (+1.20%)
At close: Sep 9, 2026 · 4:00 PM EDT

Nexentis Technologies (NXTS) Market Capitalization (2018 - 2026)

Nexentis Technologies (NXTS) posted Market Capitalization of $3.5 million for Q2 2026, up 84.85% on a QoQ basis from $1.9 million in Q4 2025, and down 97.87% year-over-year from $165.5 million in Q2 2025.

Analysis

Nexentis Technologies (NXTS) Market Capitalization (2018 - 2026) Analysis & Trends

Nexentis Technologies has reported Market Capitalization for 9 years, with the latest figure at $3.5 million in Q2 2026.

  • On a quarterly basis, Market Capitalization fell 97.87% year-over-year to $3.5 million in Q2 2026; TTM through Jun 2026 was $3.5 million, a 97.87% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, down 96.25% from the prior year.
  • Market Capitalization was $3.5 million for Q2 2026 at Nexentis Technologies, up from $1.9 million in the prior quarter.
  • The five-year high for Market Capitalization was $4.0 billion in Q1 2022, with the low at $1.9 million in Q4 2025.
  • Average Market Capitalization over 5 years is $678.9 million, with a median of $149.0 million recorded in 2025.
  • The sharpest annual moves came in 2025 and 2026: Market Capitalization jumped 190.74% in 2025, then sank 97.87% in 2026.
  • Over 5 years, Market Capitalization stood at $647.1 million in 2022, then plunged by 87.01% to $84.0 million in 2023, then sank by 39.62% to $50.7 million in 2024, then plunged by 96.25% to $1.9 million in 2025, then surged by 84.85% to $3.5 million in 2026.
  • The last three Market Capitalization figures came in at $3.5 million (Q2 2026), $1.9 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Nexentis Technologies 1.40 Mn -7.60 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.52 Mn
Dec 31, 2025 1.90 Mn
Sep 30, 2025 3.51 Mn
Jun 30, 2025 165.46 Mn
Mar 31, 2025 149.01 Mn
Dec 31, 2024 50.75 Mn
Sep 30, 2024 50.93 Mn
Jun 30, 2024 56.91 Mn
Mar 31, 2024 134.94 Mn
Dec 31, 2023 84.04 Mn
Sep 30, 2023 180.98 Mn
Jun 30, 2023 1.13 Bn
Mar 31, 2023 776.14 Mn
Dec 31, 2022 647.09 Mn
Sep 30, 2022 1.72 Bn
Jun 30, 2022 2.38 Bn
Mar 31, 2022 4.00 Bn
Dec 31, 2021 2.76 Bn
Sep 30, 2021 4.39 Bn
Jun 30, 2021 4.19 Bn